Murphy & Mullick Capital Management Corp Invests $975,000 in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Murphy & Mullick Capital Management Corp bought a new stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 1,868 shares of the medical equipment provider’s stock, valued at approximately $975,000. Intuitive Surgical comprises approximately 0.9% of Murphy & Mullick Capital Management Corp’s holdings, making the stock its 25th biggest holding.

A number of other hedge funds and other institutional investors also recently bought and sold shares of the business. Atala Financial Inc purchased a new position in Intuitive Surgical in the fourth quarter valued at approximately $25,000. Berbice Capital Management LLC acquired a new position in shares of Intuitive Surgical in the 4th quarter valued at $26,000. BankPlus Trust Department purchased a new position in shares of Intuitive Surgical in the 4th quarter valued at $28,000. Kohmann Bosshard Financial Services LLC acquired a new stake in Intuitive Surgical during the 4th quarter worth $31,000. Finally, Decker Retirement Planning Inc. purchased a new stake in Intuitive Surgical in the fourth quarter valued at $36,000. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at Intuitive Surgical

In other news, EVP Myriam Curet sold 408 shares of the company’s stock in a transaction on Tuesday, February 11th. The shares were sold at an average price of $589.75, for a total value of $240,618.00. Following the transaction, the executive vice president now directly owns 353 shares of the company’s stock, valued at approximately $208,181.75. This represents a 53.61 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, EVP Robert Desantis sold 11,545 shares of Intuitive Surgical stock in a transaction on Thursday, March 13th. The shares were sold at an average price of $499.22, for a total value of $5,763,494.90. Following the sale, the executive vice president now directly owns 5,224 shares of the company’s stock, valued at approximately $2,607,925.28. The trade was a 68.85 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 33,754 shares of company stock valued at $17,691,621 over the last three months. 0.90% of the stock is owned by corporate insiders.

Intuitive Surgical Trading Up 2.2 %

NASDAQ:ISRG opened at $519.81 on Wednesday. Intuitive Surgical, Inc. has a 1-year low of $364.17 and a 1-year high of $616.00. The business’s fifty day moving average price is $561.24 and its 200 day moving average price is $532.59. The firm has a market capitalization of $185.15 billion, a price-to-earnings ratio of 81.09, a PEG ratio of 5.85 and a beta of 1.43.

Wall Street Analysts Forecast Growth

Several research firms have recently weighed in on ISRG. Robert W. Baird decreased their price objective on Intuitive Surgical from $707.00 to $600.00 and set an “outperform” rating for the company in a report on Tuesday, March 18th. CICC Research started coverage on shares of Intuitive Surgical in a research report on Monday, January 27th. They set a “neutral” rating and a $550.00 price objective on the stock. UBS Group lifted their price objective on shares of Intuitive Surgical from $500.00 to $560.00 and gave the company a “neutral” rating in a research note on Monday, January 27th. Evercore ISI increased their target price on shares of Intuitive Surgical from $490.00 to $530.00 in a research note on Monday, January 27th. Finally, Wells Fargo & Company boosted their price target on Intuitive Surgical from $630.00 to $687.00 and gave the company an “overweight” rating in a research report on Friday, January 24th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and fifteen have assigned a buy rating to the company. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $611.86.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.